Med Gen Interviewed by Wall Street.Net

BOCA RATON, FL, (NAMC) - Med Gen Inc. (OTCBB:MGEN), manufacturers of nationally branded OTC healthier life products, was invited to be interviewed on WallSt.Net, a leading Internet informational news site reporting on companies of interest.

The interview, which can be heard in its entirety on the www.wallst.net site, targeted the company's dramatic revenue increases of 6,000%, recently reported by the company, the projected continuity of growth, the investor interest in the company which has created substantial liquidity in the company’s shares.

Highlighting events such as the planned new television commercials for its UnDiet® weight loss system, the introduction of new unique products featuring the company’s STW® spray delivery system and the recent high approval ratings in Health and Wellness Club and PGA Golf club for its Painenz®, Mr. Paul Kravitz, Chairman and CEO, takes the listener through the up-beat highs of Med Gen’s future growth opportunities prevalent within the $100 billion market in which its products compete.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray’s the Way (“STW”). It is best known for producing the world’s first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the UnDiet® system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names.

Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol “MGEN”. For information contact Investor Relations 561-750-1100 or www.medgen.com

This Press Release contains or incorporates by reference “forward-looking” statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.